Applied Biology, Inc.
Clinical trials sponsored by Applied Biology, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New scalp treatment for hair loss under study Results expected Oct 2026 (estimated)
- New drug aims to stop chemo hair loss in its tracks Results expected Feb 2027 (estimated)
- New DA-001 hair loss treatment heads to Large-Scale trial Results expected Mar 2027 (estimated)
- Can a cream turn back the clock on grey hair? new trial begins Results expected Jun 2027 (estimated)
-
New drug aims to stop chemo hair loss in its tracks
Prevention Recruiting nowThis study tests a new treatment called DA-020 to prevent hair loss in people with early-stage breast cancer receiving chemotherapy. About 60 participants will use DA-020 during their chemo sessions. The goal is to see if it can reduce hair loss and help hair grow back faster aft…
Phase 1/2 • Sponsor: Applied Biology, Inc. • Aim: Prevention
Last updated Aug 23, 2026 00:00 UTC
-
Could a scalp gel save your hair during chemo? early trial begins
Symptom relief Recruiting nowThis early-phase trial tests a topical phenylephrine gel applied daily to the scalp for three weeks. Researchers want to see how much of the drug enters the bloodstream and whether it is safe. The study involves 24 healthy women aged 18-55, not cancer patients, so it is a first s…
Early phase 1 • Sponsor: Applied Biology, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC